CoChat

Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints

Open access
Pabla, Navjotsingh, Bhatt, Kirti, Dong, Zheng · 2012 · Proceedings of the National Academy of Sciences
Cited by 66

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Checkpoint kinase 1 (Chk1) is a key regulator of checkpoint signaling in both the unperturbed cell cycle and DNA damage response. Under these conditions, Chk1 becomes active to prevent premature CDK1 activation and mitotic entry until DNA is properly replicated or repaired. It is unclear how Chk1 activity is controlled in the unperturbed cell cycle. During DNA damage, Chk1 is activated by ataxia telangiectasia and Rad3 related (ATR)-mediated phosphorylation; however, it is not entirely clear how this phosphorylation results in Chk1 activation. Here we report an N-terminally truncated alternative splice variant of Chk1, Chk1-S. Importantly, we show that Chk1-S is an endogenous repressor and regulator of Chk1. In the unperturbed cell cycle, Chk1-S interacts with and antagonizes Chk1 to promote the S-to-G2/M phase transition. During DNA damage, Chk1 is phosphorylated, which disrupts the Chk1–Chk1-S interaction, resulting in free, active Chk1 to arrest the cell cycle and facilitate DNA repair. Higher levels of Chk1-S are expressed, along with Chk1, in fetal and cancer tissues than in normal tissues. However, forced overexpression of Chk1-S in cultured cells and tumor xenografts induces premature mitotic entry, mitotic catastrophe, and reduction of tumor growth. The identification of Chk1-S as a unique splice variant and key regulator of Chk1 provides insights into cell cycle regulation and DNA damage response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.1104767109

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 30

  1. P Nurse, A long twentieth century of the cell cycle and beyond. Cell 100, 71–78 (2000). · DOI · Paper page
  2. AG Paulovich, DP Toczyski, LH Hartwell, When checkpoints fail. Cell 88, 315–321 (1997). · DOI · Paper page
  3. N Walworth, S Davey, D Beach, Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2. Nature 363, 368–371 (1993). · DOI · Paper page
  4. H Takai, et al., Aberrant cell cycle checkpoint function and early embryonic death in Chk1(−/−) mice. Genes Dev 14, 1439–1447 (2000). · DOI · Paper page
  5. J Bartek, J Lukas, Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3, 421–429 (2003). · DOI · Paper page
  6. NC Walworth, Cell-cycle checkpoint kinases: Checking in on the cell cycle. Curr Opin Cell Biol 12, 697–704 (2000). · DOI
  7. G Zachos, DA Gillespie, Exercising restraints: Role of Chk1 in regulating the onset and progression of unperturbed mitosis in vertebrate cells. Cell Cycle 6, 810–813 (2007). · DOI
  8. K Zaugg, et al., Cross-talk between Chk1 and Chk2 in double-mutant thymocytes. Proc Natl Acad Sci USA 104, 3805–3810 (2007). · DOI
  9. MJ O'Connell, JM Raleigh, HM Verkade, P Nurse, Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. EMBO J 16, 545–554 (1997). · DOI · Paper page
  10. J Lee, A Kumagai, WG Dunphy, Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 12, 551–563 (2001). · DOI · Paper page
  11. A Lopez-Girona, B Furnari, O Mondesert, P Russell, Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397, 172–175 (1999). · DOI · Paper page
  12. C Feijoo, et al., Activation of mammalian Chk1 during DNA replication arrest: A role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing. J Cell Biol 154, 913–923 (2001). · DOI · Paper page
  13. CS Sørensen, et al., Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247–258 (2003). · DOI · Paper page
  14. E Petermann, et al., Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol Cell Biol 26, 3319–3326 (2006). · DOI · Paper page
  15. G Zachos, et al., Chk1 is required for spindle checkpoint function. Dev Cell 12, 247–260 (2007). · DOI · Paper page
  16. J Tang, RL Erikson, X Liu, Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1). Proc Natl Acad Sci USA 103, 11964–11969 (2006). · DOI · Paper page
  17. D Wilsker, E Petermann, T Helleday, F Bunz, Essential function of Chk1 can be uncoupled from DNA damage checkpoint and replication control. Proc Natl Acad Sci USA 105, 20752–20757 (2008). · DOI · Paper page
  18. Y Katsuragi, N Sagata, Regulation of Chk1 kinase by autoinhibition and ATR-mediated phosphorylation. Mol Biol Cell 15, 1680–1689 (2004). · DOI · Paper page
  19. M Walker, EJ Black, V Oehler, DA Gillespie, MT Scott, Chk1 C-terminal regulatory phosphorylation mediates checkpoint activation by de-repression of Chk1 catalytic activity. Oncogene 28, 2314–2323 (2009). · DOI · Paper page
  20. C Tapia-Alveal, TM Calonge, MJ O'Connell, Regulation of Chk1. Cell Div 4, 8 (2009). · DOI
  21. P Chen, et al., The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1: Implications for Chk1 regulation. Cell 100, 681–692 (2000). · DOI · Paper page
  22. A Krämer, J Lukas, J Bartek, Checking out the centrosome. Cell Cycle 3, 1390–1393 (2004). · DOI
  23. A Krämer, et al., Centrosome-associated Chk1 prevents premature activation of cyclin-B-Cdk1 kinase. Nat Cell Biol 6, 884–891 (2004). · DOI · Paper page
  24. MH Lam, Q Liu, SJ Elledge, JM Rosen, Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6, 45–59 (2004). · DOI · Paper page
  25. T Fishler, et al., Genetic instability and mammary tumor formation in mice carrying mammary-specific disruption of Chk1 and p53. Oncogene 29, 4007–4017 (2010). · DOI · Paper page
  26. H Capasso, et al., Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest. J Cell Sci 115, 4555–4564 (2002). · DOI · Paper page
  27. C Latif, NR den Elzen, MJ O'Connell, DNA damage checkpoint maintenance through sustained Chk1 activity. J Cell Sci 117, 3489–3498 (2004). · DOI
  28. Y Dai, S Grant, New insights into checkpoint kinase 1 in the DNA damage response signaling network. Clin Cancer Res 16, 376–383 (2010). · DOI · Paper page
  29. C Merry, K Fu, J Wang, IJ Yeh, Y Zhang, Targeting the checkpoint kinase Chk1 in cancer therapy. Cell Cycle 9, 279–283 (2010). · DOI
  30. CX Ma, JW Janetka, H Piwnica-Worms, Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol Med 17, 88–96 (2011). · DOI · Paper page

Cited by

See all 66

Metadata

Authors
Pabla, N., Bhatt, K., & Dong, Z.
Venue
Proceedings of the National Academy of Sciences
Published
2011-12-19
Volume
109
Issue
1
Pages
197-202
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2134487183
Cited by
66
References
13
FWCI
1.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.